Skeletal Effects of Chronic Night Shift
ACORN
2 other identifiers
observational
40
1 country
1
Brief Summary
The specific aim of this observational study is to characterize changes in bone turnover makers (BTMs), bone mineral density (BMD), and bone microarchitecture in a cohort of nurses during their first year of night compared to day shift work. The hypothesis is that night shift nurses will have poorer bone health indices at one year compared to day shift nurses.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 29, 2021
CompletedFirst Posted
Study publicly available on registry
October 25, 2021
CompletedStudy Start
First participant enrolled
October 27, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2026
CompletedJuly 30, 2025
May 1, 2025
4.3 years
September 29, 2021
July 25, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Difference in change of propeptide of type 1 procollagen (P1NP) over 1 year
Difference in change of P1NP over 1 year between the two groups (night vs. day shift nurses), as measured via bone biomarker assays (immunodiagnostic systems, chemiluminescence, immunoassay)
From baseline up to 12 months
Secondary Outcomes (4)
Between-group differences in the change in osteocalcin
From baseline up to 12 months
DXA-derived areal bone mineral density (aBMD) changes
From baseline up to 12 months
Change in bone microarchitecture
From baseline up to 12 months
Between-group differences in the change in CTX (C-telopeptide of type I collagen)
From baseline up to 12 months
Study Arms (2)
University of Colorado Health New Nurses (Day Shift Workers)
Day shift work group nurses have greater than 50% of their shifts as day shifts.
University of Colorado Health New Nurses (Night Shift Workers)
Night shift work group nurses have greater than 50% of their shifts as night shifts.
Eligibility Criteria
We will recruit volunteers from the pool of recently graduated new nurse hires at UCH. We will target our recruitment towards units that work the night shift (floor/ICU units) or day shifts (peri-operative and operating room units).
You may qualify if:
- Healthy, nonpregnant adults 20-50 years old who recently (≤6 months) graduated from nursing school and were hired by University of Colorado Hospital for their first nursing position
- For women to be eligible, they must be premenopausal, not breastfeeding, not pregnant with no plans to become pregnant during the year of observation and willing/able to maintain their current method of contraception use as detailed below.
- Willing and able to travel to/from CU-AMC for study measurements at baseline and quarterly for one full year
You may not qualify if:
- Current smokers at baseline (or within the previous year of study).
- Individuals who are concurrently participating in another research protocol that would influence their safe participation in this study. For example, participants involved in a study that requires blood draws or ingestion of experimental medication as this would increase the risk of participation in our study and/or compromise study results.
- Self-reported or newly diagnosed medical condition that is still being investigated or is not under good control, including those identified on screening labs such as:
- o Out-of-range values measured on a blood sample such as glucose, TSH, creatinine or hemoglobin, that represent clinically significant abnormalities that may jeopardize safe participation or accuracy of outcome measures, at PI discretion
- Evaluation of Psychiatric/Psychological Suitability:
- Inability to demonstrate a full understanding of the requirements and demands of the study.
- Individuals who are unaware of specific psychiatric diagnoses who have a history of having been treated with antidepressants, neuroleptic medications or major tranquilizers will be excluded from study.
- Individuals with any clinically significant sleep disorder; Diagnosis or symptoms of sleep disorders (history of significant parasomnia as an adult \[night terrors, frequent sleep walking\], insomnia, including but not limited to hypersomnias such as apnea, periodic limb movements, narcolepsy). Sleep disorders will be screened by self-report and physician interview including use of validated sleep questionnaires (PSQI, Epworth sleepiness scale, and Berlin sleep questionnaire for sleep apnea).
- Individuals on medications known to affect bone turnover (e.g., glucocorticoids, osteoporosis medications);
- Individuals with eGFR \< 60 mL/min/1.73m2 as this is known to affect CTX measurements.
- Symptoms of active illness (e.g., fever) at time of enrollment; note - participant may be studied at a later date if they have not yet started their clinical duties by that time
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CU Anschutz
Aurora, Colorado, 80045, United States
Biospecimen
Blood serum, plasma
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christine M Swanson, MD, MCR
CU Anschutz
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 29, 2021
First Posted
October 25, 2021
Study Start
October 27, 2021
Primary Completion
February 28, 2026
Study Completion
February 28, 2026
Last Updated
July 30, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share